Boston, MA – Patient engagement has been a common theme in our trend reports. There is an increasing want from consumers to obtain their health records. The OpenNotes Project has the potential to add to that engagement in a huge way and has just received new joint backing from Cambria Health Foundation, Gordon and Betty Moore Foundation, Peterson Center on Healthcare, and the Robert Wood Johnson Foundation. If you aren’t familiar the project is based around the simple goal to enable patients to see their doctors’ visit notes. This is done by opening up access to EHR data. There have been several trials involving OpenNotes and, “the research shows increasingly that patients can benefit greatly from reading the notes taken during a medical visit. They tell us they feel more in control of their care and are more likely to follow up on recommendations,” said Jan Walkeheatr, RN, MBA, co-founder of OpenNotes and Assistant Professor of Medicine at Harvard Medical School and BIDMC. This powerful new tool boasts that 99 percent of patients wanted to continue with open access after the study ended.

About the Author:

As Managing Director of Innovation for Syneos Health Communications, Leigh is responsible for shaping the company’s perspective on the next era of healthcare marketing. Through thought leadership, strategic innovation workshops and new products and capabilities, Leigh focuses on identifying marketing approaches that will fuel that new era and generate significant growth for clients. Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for over 17 years. She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she had several leadership roles at one of our agencies, GSW. There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business. Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes. A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice, Leigh also was recognized as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.